Article

ForbesForbes on 2021-03-18 14:00

What’s Next For Intellia Therapeutics Stock After A 15% Rise In A Week?

The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a solid 15% rise ...

Related news